跳至主要内容
临床试验/IRCT20190514043586N1
IRCT20190514043586N1已完成3 期

comparison of the efficacy and complication of two medication regimen 'naproxen and loratadin’ with 'acetaminophen and loratadin' on relief of bone pain due to PEG G-csf in patients with solid tumors chemotherapy

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • People with Solid Tumor or Lymphoma who receive PEG G-CSF due to neutropenia after chemotherapy

排除标准

  • Bone matastasis
  • PFS more than 2
  • Osteomalacia proven with laboratory tests
  • CKD or ESRD
  • Active Rheumatologic disease
  • Uncontrolled Diabetes or Thyroid disease
  • Patients receiving chemotherapy drugs that have bone pain are a high prevalence of 10% (TAXAN family, bisphosphonate ...)
  • Pathologic fracture or fracture due to any reason
  • Naproxen use contraindication
  • Vitamin D level less than 20
  • Paget disease
  • Hyperparathyroidism
  • People who have had a score of over 6 in the bone pain score since the beginning of the project
  • Liver disease
  • History of Cardiac Arrhythmia
  • Patient who have not compliance for completing pain questionnaire

研究者

相似试验